Overview

Carcinoid tumors are a type of slow-growing cancer that can arise in several places throughout your body. Carcinoid tumors, which are one subset of tumors called neuroendocrine tumors, usually begin in the digestive tract (stomach, appendix, small intestine, colon, rectum) or in the lungs.

Carcinoid tumors often don't cause signs and symptoms until late in the disease. Carcinoid tumors can produce and release hormones into your body that cause signs and symptoms such as diarrhea or skin flushing.

Treatment for carcinoid tumors usually includes surgery and may include medications.

Symptoms

Some carcinoid tumors don't cause any signs or symptoms. When they do occur, signs and symptoms are usually vague and depend on the location of the tumor.

Carcinoid tumors in the lungs

Signs and symptoms of carcinoid lung tumors include:

  • Chest pain
  • Wheezing
  • Shortness of breath
  • Diarrhea
  • Redness or a feeling of warmth in your face and neck (skin flushing)
  • Weight gain, particularly around the midsection and upper back
  • Pink or purple marks on the skin that look like stretch marks

Carcinoid tumors in the digestive tract

Signs and symptoms of carcinoid tumors in the digestive tract include:

  • Abdominal pain
  • Diarrhea
  • Nausea, vomiting and inability to pass stool due to intestinal blockage (bowel obstruction)
  • Rectal bleeding
  • Rectal pain
  • Redness or a feeling of warmth in your face and neck (skin flushing)

When to see a doctor

If you experience any signs and symptoms that bother you and are persistent, make an appointment with your doctor.

Get Mayo Clinic cancer expertise delivered to your inbox.

Subscribe for free and receive an in-depth guide to coping with cancer, plus helpful information on how to get a second opinion. You can unsubscribe at any time. Click here for an email preview.

I would like to learn more about

To provide you with the most relevant and helpful information, and understand which information is beneficial, we may combine your email and website usage information with other information we have about you. If you are a Mayo Clinic patient, this could include protected health information. If we combine this information with your protected health information, we will treat all of that information as protected health information and will only use or disclose that information as set forth in our notice of privacy practices. You may opt-out of email communications at any time by clicking on the unsubscribe link in the e-mail.

Causes

It's not clear what causes carcinoid tumors. In general, cancer occurs when a cell develops mutations in its DNA. The mutations allow the cell to continue growing and dividing when healthy cells would normally die.

The accumulating cells form a tumor. Cancer cells can invade nearby healthy tissue and spread to other parts of the body.

Doctors don't know what causes the mutations that can lead to carcinoid tumors. But they know that carcinoid tumors develop in neuroendocrine cells.

Neuroendocrine cells are found in various organs throughout the body. They perform some nerve cell functions and some hormone-producing endocrine cell functions. Some hormones that are produced by neuroendocrine cells are histamine, insulin and serotonin.

Risk factors

Factors that increase the risk of carcinoid tumors include:

  • Older age. Older adults are more likely to be diagnosed with a carcinoid tumor than are younger people or children.
  • Sex. Women are more likely than men to develop carcinoid tumors.
  • Family history. A family history of multiple endocrine neoplasia, type 1 (MEN 1), increases the risk of carcinoid tumors. In people with MEN 1 multiple tumors occur in glands of the endocrine system.

Complications

The cells of carcinoid tumors can secrete hormones and other chemicals, causing a range of complications including:

  • Carcinoid syndrome. Carcinoid syndrome causes redness or a feeling of warmth in your face and neck (skin flushing), chronic diarrhea, and difficulty breathing, among other signs and symptoms.
  • Carcinoid heart disease. Carcinoid tumors may secrete hormones that can cause thickening of the lining of heart chambers, valves and blood vessels. This can lead to leaky heart valves and heart failure that may require valve-replacement surgery. Carcinoid heart disease can usually be controlled with medications.
  • Cushing syndrome. A lung carcinoid tumor can produce an excess of a hormone that can cause your body to produce too much of the hormone cortisol.

Dec. 06, 2022

Living with carcinoid tumors?

Connect with others like you for support and answers to your questions in the Neuroendocrine Tumors (NETs) support group on Mayo Clinic Connect, a patient community.

Neuroendocrine Tumors (NETs) Discussions

ssf
Has anyone out there tried Histotripsy for tumors in the liver?

39 Replies Fri, Dec 13, 2024

markmark007
Questions about Blood Tests Results after PRRT treatment

12 Replies Sat, Dec 07, 2024

shanda
Paraganglioma / Carotid Body Tumor Question

116 Replies Fri, Nov 29, 2024

See more discussions
  1. Melmed S, et al. Neuroendocrine tumors and related disorders. In: Williams Textbook of Endocrinology. 14th ed. Elsevier; 2020. https://www.clinicalkey.com. Accessed Dec. 15, 2020.
  2. Neuroendocrine and adrenal tumors. National Comprehensive Cancer Network. https://www.nccn.org/professionals/physician_gls/default.aspx. Accessed Dec. 15, 2020.
  3. Feldman M, et al., eds. Neuroendocrine tumors. In: Sleisenger and Fordtran's Gastrointestinal and Liver Disease: Pathophysiology, Diagnosis, Management. 11th ed. Elsevier; 2021. https://www.clinicalkey.com. Accessed Dec. 15, 2020.
  4. Goldman L, et al., eds. Neuroendocrine tumors. In: Goldman-Cecil Medicine. 26th ed. Elsevier; 2020. https://www.clinicalkey.com. Accessed Dec. 15, 2020.
  5. Gastrointestinal carcinoid tumors treatment (Adult) (PDQ) — Health professional version. National Cancer Institute. https://www.cancer.gov/types/gi-carcinoid-tumors/hp/gi-carcinoid-treatment-pdq. Accessed Feb. 16, 2021.
  6. Cives M, et al. Gastroenteropancreatic neuroendocrine tumors. CA: A Cancer Journal for Clinicians. 2018; doi:10.3322/caac.21493.
  7. Fact sheet: What is peptide receptor radionuclide therapy (PRRT)? Society of Nuclear Medicine and Molecular Imaging. https://www.snmmi.org/AboutSNMMI/Content.aspx?ItemNumber=29883. Accessed Feb. 16, 2021.